|
|
| TARG9 / Xintela (0 Trials) |
|
| Target lost antigens cell therapies / A2 Biotherap (0 Trials) |
|
| Target-11 / Cerevance (0 Trials) |
|
| Target-16 / Cerevance (0 Trials) |
|
| Target-17 / Cerevance (0 Trials) |
|
| Target-18 / Cerevance (0 Trials) |
|
| target-activated natural killer cell therapy / ImmunityBio (0 Trials) |
|
| targetaSN / Evotec (0 Trials) |
|
| Targeted Fragile X Syndrome therapeutic / Vencerx Therap (0 Trials) |
|
| targetPicV / Bayer, Evotec, Horizon Discovery (0 Trials) |
|
| Targets for cardiovascular disease / Merck (MSD) (0 Trials) |
|
| TargomiR (EGFREDVmiR-16) / EnGeneIC, Asbestos Diseases Research Institute (1 Trials) |
|
| Targretin gel (bexarotene topical) / Eisai, Bausch Health (1 Trials) |
|
| Targretin oral (bexarotene oral) / ReXceptor (5 Trials) |
|
| Tarlige (mirogabalin) / Daiichi Sankyo (4 Trials) |
|
| Tarlox (tarloxotinib bromide) / Pathos (2 Trials) |
|
| TARP dendritic cell vaccine / PDS Biotech (0 Trials) |
|
| tarperprumig (ALXN1820) / AstraZeneca (0 Trials) |
|
| Tarpeyo (budesonide) / Calliditas, Stada (1 Trials) |
|
| Tarvacin (bavituximab) / OncXerna Therap (2 Trials) |
|
| TAS-108 / Otsuka, Nobelpharma, SRI International (0 Trials) |
|
| TAS-114 / Otsuka (0 Trials) |
|
| TAS-121 / Otsuka (0 Trials) |
|
| TAS-2913 / Otsuka (0 Trials) |
|
| TAS-2985 / Otsuka (0 Trials) |
|
| TAS-303 / Otsuka (0 Trials) |
|
| TAS0286 / Otsuka, Helsinn (0 Trials) |
|
| TAS0313 / Otsuka (0 Trials) |
|
| TAS05567 / Otsuka (0 Trials) |
|
| TAS0612 / Otsuka (0 Trials) |
|
| TAS0728 / Otsuka (1 Trials) |
|
| TAS1440 / Otsuka (0 Trials) |
|
| TAS1553 / Otsuka (0 Trials) |
|
| TAS2940 / Otsuka (0 Trials) |
|
| TAS3351 / Otsuka (0 Trials) |
|
| TAS3681 / Otsuka (1 Trials) |
|
| TAS4464 / Otsuka (0 Trials) |
|
| TAS5315 / Otsuka (0 Trials) |
|
| tasadenoturev (DNX-2401) / DNAtrix (3 Trials) |
|
| taselisib (GDC-0032) / Roche (3 Trials) |
|
| Tasfygo (tasurgratinib) / Eisai (1 Trials) |
|
| Tasigna (nilotinib) / Novartis, Inhibikase (62 Trials) |
|
| tasisulam (LY573636) / Eli Lilly (0 Trials) |
|
| TASP0277308 / Taisho (0 Trials) |
|
| TASP0412098 / Taisho (0 Trials) |
|
| taspoglutide (BIM51077) / Ipsen (0 Trials) |
|
| tasquinimod (ABR-215050) / Active Biotech, Ipsen (4 Trials) |
|
| Tat Oyi / Biosantech (0 Trials) |
|
| TatImmune (tat protein based HIV vaccine) / Vaxxit (0 Trials) |
|
| TATX-03 / ImmunoPrecise (0 Trials) |
|
| TATX-112 / ImmunoPrecise (0 Trials) |
|
| tau inhibitor / APRINOIA Therap (0 Trials) |
|
| Tauferon (IFN-τ) / Pepgen Corp (0 Trials) |
|
| Tavalisse (fostamatinib) / Rigel (13 Trials) |
|
| tavapadon (CVL-751) / AbbVie (2 Trials) |
|
| TAvi6 / Roche (0 Trials) |
|
| tavilermide (MIM-D3) / Mimetogen (0 Trials) |
|
| Tavin-LN kit (tenofovir/lamivudine/nevirapine) / Emcure (0 Trials) |
|
| Tavneos (avacopan) / Amgen (7 Trials) |
|
| Tavo (tavokinogene telsaplasmid) / OncoSec (3 Trials) |
|
| TAVO101 / Tavotek (0 Trials) |
|
| Tavo103 / Tavotek (0 Trials) |
|
| Tavo111 / Tavotek (0 Trials) |
|
| TAVO412 / Tavotek (0 Trials) |
|
| Tavocept (dimesna) / BioNumerik, Lantern Pharma (1 Trials) |
|
| tavolixizumab (MEDI0562) / AstraZeneca (2 Trials) |
|
| TAVT-135 / Tavanta Therap (0 Trials) |
|
| Taxoprexin (DHA-paclitaxel) / Daiichi Sankyo (0 Trials) |
|
| Taxosomes (paclitaxel nanosomal) / Aphios (0 Trials) |
|
| TAY018 / TOT Biopharm (0 Trials) |
|
| tazarotene oral (GRI-0621) / GRI Bio (1 Trials) |
|
| tazarotene topical / Generic mfg. (3 Trials) |
|
| Tazverik (tazemetostat) / Ipsen (29 Trials) |
|
| TB-100 / Therabest (0 Trials) |
|
| TB-101 / Peptron, Therabest (0 Trials) |
|
| TB-200 / Therabest (0 Trials) |
|
| TB-201 / Therabest, Peptron (0 Trials) |
|
| TB-219 / Therabest (0 Trials) |
|
| TB-301 / Therabest (0 Trials) |
|
| TB-402 / Y's Therap (0 Trials) |
|
| TB-403 / Oxurion (0 Trials) |
|
| TB-840 / Therasid Biosci (0 Trials) |
|
| TB-ADC-01 / Theragen Bio (0 Trials) |
|
| TB-ADC-02 / Theragen Bio (0 Trials) |
|
| TB-CV-01 / Theragen Bio (0 Trials) |
|
| TB-CV-02 / Theragen Bio (0 Trials) |
|
| TB-SM-01 / Theragen Bio (0 Trials) |
|
| TB006 / TrueBinding (0 Trials) |
|
| TB31F / Radboud University, PATH (0 Trials) |
|
| TBA-7371 / Bill & Melinda Gates Foundation, Global Alliance for TB Drug Development, Foundation for Neglected Disease Research (0 Trials) |
|
| TBAJ-876 / Global Alliance for TB Drug Development (0 Trials) |
|
| TBI 1201 / Takara (0 Trials) |
|
| TBI 302 / Resilience (0 Trials) |
|
| TBI-1501 / Takara (1 Trials) |
|
| TBI-2002 / Takara (0 Trials) |
|
| TBI-223 / Global Alliance for TB Drug Development (0 Trials) |
|
| TBio-6517 / Turnstone Biologics (0 Trials) |
|
| TBL-100 / TauC3 Bio (0 Trials) |
|
| TBS-3 / Acerus (0 Trials) |
|
| TBS-5 / Acerus (0 Trials) |
|
| TBX-03 / TheraBiologics (0 Trials) |
|
| TBX-1400 / Taiga Biotech (1 Trials) |
|
| TBX-2400 / Taiga Biotech (0 Trials) |
|
| TBX-3400 / Taiga Biotech (0 Trials) |
|
| TC 7020 / Catalyst Biosci (0 Trials) |
|
| TC-110 / Adaptimmune (0 Trials) |
|
| TC-2429 / Catalyst Biosci (0 Trials) |
|
| TC-310 / Adaptimmune (0 Trials) |
|
| TC-510 / Adaptimmune (0 Trials) |
|
| TC-6987 / Catalyst Biosci (0 Trials) |
|
| TC-8831 / Catalyst Biosci (0 Trials) |
|
| TC-A101 / TCRCure, Xinqiao Hospital (0 Trials) |
|
| TCB003 / TC Biopharm, NIPRO Corp (0 Trials) |
|
| TCB004 / TC Biopharm, Regeneron (0 Trials) |
|
| TCB005 / TC Biopharm (0 Trials) |
|
| TCB006 / TC Biopharm (0 Trials) |
|
| TCB009 / TC Biopharm (0 Trials) |
|
| TCC1727 / Sino Biopharm (0 Trials) |
|
| tCellVax / Regen BioPharma (0 Trials) |
|
| Tcelna (imilecleucel-T) / EMD Serono, Zevra Therap (0 Trials) |
|
| TCK-276 / Teijin (0 Trials) |
|
| TCM-606F / TCM Biotech (0 Trials) |
|
| TCMCB07 / Endevica, WuXi AppTec (0 Trials) |
|
| TCN-202 / Theraclone Sciences (0 Trials) |
|
| TCR discovery for stem to T-cell program / EOM Pharma (0 Trials) |
|
| TCR-based therapy / Engimmune (0 Trials) |
|
| TCR-deficient NKR T-cell therapy / Celyad Oncology (0 Trials) |
|
| TCR-NK-X / Karolinska Institute, Zelluna (0 Trials) |
|
| TCR-T cell immunotherapy / National University of Singapore (0 Trials) |
|
| TCRT-ESO-A2 / Axis Therap (0 Trials) |
|
| TCRx_T / TCRx Therap, Zhejiang University (0 Trials) |
|
| TD-0714 / Theravance Biopharma (0 Trials) |
|
| TD-1058 / Theravance Biopharma (0 Trials) |
|
| TD-1211 / Innoviva (0 Trials) |
|
| TD-1439 / Theravance Biopharma (0 Trials) |
|
| TD-1607 / Theravance Biopharma (0 Trials) |
|
| TD-6450 / Innoviva, Trek Therapeutics (0 Trials) |
|
| TD-8236 / Theravance Biopharma (0 Trials) |
|
| Td-Impfstoff Merieux / Sanofi (0 Trials) |
|
| TD567 / OB Pharma (0 Trials) |
|
| TDENV-PIV / GSK, U.S. Army Medical Research and Development Command (0 Trials) |
|
| TDI01 / Graviton Biosci (0 Trials) |
|
| TDM-105795 / Therapeutics Inc (0 Trials) |
|
| TDM-180935 / TechnoDerma Medicines (0 Trials) |
|
| TDP-43 antibodies / ImStar Therap (0 Trials) |
|
| TDP521252 / J&J (0 Trials) |
|
| TDP665759 / J&J (0 Trials) |
|
| TDT 044 / Celtic Pharma (0 Trials) |
|
| TDT 077 / Celtic Pharma (0 Trials) |
|
| Te'erjin (filgrastim biosimilar) / Dongbao Enterprise Group (0 Trials) |
|
| TE-1146 / T-E Pharma (0 Trials) |
|
| TE-1254 / T-E Pharma (0 Trials) |
|
| TE-2324 / T-E Pharma (0 Trials) |
|
| TE-5315 / T-E Pharma (0 Trials) |
|
| tebanicline (ABT-594) / AbbVie (0 Trials) |
|
| tebapivat (AG-946) / Agios Pharma (0 Trials) |
|
| Teberif (interferon beta-1a biosimilar) / Biocad (0 Trials) |
|
| tebotelimab (MGD013) / MacroGenics (6 Trials) |
|
| tecadenoson (CVT-510) / Gilead (0 Trials) |
|
| tecaginlimab (GEN1042) / Genmab, BioNTech (0 Trials) |
|
| tecarfarin (ATI-5923) / Cadrenal Therapeutics (1 Trials) |
|
| Tecartus (brexucabtagene autoleucel) / Gilead (0 Trials) |
|
| Tecelra (afamitresgene autoleucel) / Adaptimmune (3 Trials) |
|
| Tecentriq (atezolizumab) / Roche (532 Trials) |
|
| Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs) / Roche (0 Trials) |
|
| Technivie (ombitasvir/paritaprevir/ritonavir) / AbbVie (4 Trials) |
|
| tecotabart vedotin (LM-302) / LaNova Medicines Limited (0 Trials) |
|
| Tectin (tetrodotoxin) / CK Life Sci (1 Trials) |
|
| Tecvayli (teclistamab-cqyv) / Genmab, J&J (1 Trials) |
|
| TED-A9 / S.Biomedics (0 Trials) |
|
| tedalinab (GRC-10693) / Glenmark (0 Trials) |
|
| tedatioxetine (Lu AA24530) / Takeda, Lundbeck (0 Trials) |
|
| Tedopi (OSE 2101) / OSE Immunotherapeutics (4 Trials) |
|
| teduglutide (NM-003) / 9 Meters Biopharma (0 Trials) |
|
| Tefina (testosterone intranasal) / Acerus (0 Trials) |
|
| tefinostat (CHR-2845) / Chroma Therap (1 Trials) |
|
| Tefsole (baclofen) / VHB Life Sci (0 Trials) |
|
| TEG001 / Century Therap (0 Trials) |
|
| tegafur/uracil / Generic mfg. (3 Trials) |
|
| tegavivint (BC2059) / Iterion Therap (0 Trials) |
|
| tegileridine (SHR8554) / Jiangsu Hengrui Pharma (0 Trials) |
|
| teglarinad (GMX1777) / Teva (0 Trials) |
|
| Teglutik (riluzole oral suspension) / Italfarmaco (0 Trials) |
|
| tegobuvir (GS 9190) / Gilead (0 Trials) |
|
| tegoprubart (AT-1501) / Eledon (0 Trials) |
|
| Tegsedi (inotersen) / Ionis, SOBI (0 Trials) |
|
| teicoplanin / Generic mfg. (25 Trials) |
|
| Tekamlo (aliskiren/amlodipine) / Novartis (0 Trials) |
|
| Tekturna (aliskiren) / PDL (12 Trials) |
|
| telacebec (Q203) / Qurient (0 Trials) |
|
| telaglenastat (CB-839) / Calithera (11 Trials) |
|
| telanmir / Advanced Medical Projects (0 Trials) |
|
| telatinib (BAY 57- 9352) / EddingPharm (1 Trials) |
|
| telazorlimab (ISB 830) / Astria Therap (0 Trials) |
|
| telbermin (sNN-0029) / Newron (0 Trials) |
|
| telcagepant (MK-0974) / Merck (MSD) (0 Trials) |
|
| Telcyta (canfosfamide) / MabVax (0 Trials) |
|
| teleukin (F16-IL2) / Philogen (1 Trials) |
|
| Telintra (ezatiostat) / MabVax (0 Trials) |
|
| telisotuzumab (h224G11) / AbbVie (0 Trials) |
|
|